Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia

References

Page 1

	Year	Citations
Radioreceptor Binding Profile of the Atypical Antipsychotic Olanzapine Frank P. Bymaster, David O. Calligaro, Julie F. Falcone, Neuropsychopharmacology NeuropsychologyPsychoactive DrugPsychiatryMedicineRadioreceptor Binding Profile	1996	1.1K
Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice Susan E. Hamilton, Michael D. Loose, Ming Qi, Proceedings of the National Academy of Sciences NeurotransmitterMuscarinic Acetylcholine ReceptorsNeural Stem CellSynaptic SignalingCellular Physiology	1997	363
Tissue pH as an indicator of mRNA preservation in human post-mortem brain Ann E. Kingsbury, Oliver Foster, Angus Nisbet, Molecular Brain Research Mrna PreservationNeuroanatomyCellular NeurosciencePhysiologyHuman Post-mortem Brain	1995	321
5-HT1A and 5-HT2A Receptor mRNAs and Binding Site Densities Are Differentially Altered in Schizophrenia Philip W. J. Burnet Neuropsychopharmacology 5-Ht2a Receptor MrnasPsychiatrySchizophreniaNeuroscienceBiological Psychiatry	1996	288
Differential Regulation of Molecular Subtypes of Muscarinic Receptors in Alzheimer's Disease Donna D. Flynn, Gaby Ferrari‐DiLeo, Deborah C. Mash, Journal of Neurochemistry	1995	233
Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation Jeremy M. Crook, Eva Tomaskovic‐Crook, David Copolov, Biological Psychiatry NeuropsychologyPsychiatryPsychotic DisorderMedicinePsychotropic Medication	2000	227
Low Muscarinic Receptor Binding in Prefrontal Cortex From Subjects With Schizophrenia: A Study of Brodmann’s Areas 8, 9, 10, and 46 and the Effects of Neuroleptic Drug Treatment Jeremy M. Crook, Eva Tomaskovic‐Crook, David Copolov, American Journal of Psychiatry	2001	224
Delta Sleep Deficits in Schizophrenia Matcheri S. Keshavan, Charles F. Reynolds, Jean M. Miewald, Archives of General Psychiatry	1998	185
Xanomeline, an M1/M4 preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice Harlan E. Shannon, Kurt Rasmussen, Frank P. Bymaster, Schizophrenia Research Antipsychotic-like ActivityPsychiatryMedicinePsychopharmacologyNeuropharmacology	2000	159
The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia. Brian Dean, Jeremy M. Crook, Kenneth Opeskin, PubMed	1996	149

Page 1